$57.06 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 10

Data Bits

Data Bits Value / Change Benchmark
Job Posts 15 7.1%
Sentiment 70 0%
Webpage traffic 87,000 24.7%
Employee Rating 65 0%
Google Adspend $12,371 -47.8%
Google Trends 41 -42.3%
Linkedin Employees 622 N/A
Patents 55 0%
4chan Mentions 0%
Facebook Engagement 1,928 16.1%
Facebook followers 1,868 0.1%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 602 0%
Youtube Subscribers 2,120 0%
Instagram Followers 2,914 0.1%
News Mentions 0%
Reddit Mentions 0%
Business outlook 68 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Axonics

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction.

Price $57.06
Target Price Sign up
Market Cap $2.93B
Dividend Yield 0
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2393M86M69M3.9M1.6M
Q2 '2393M81M70M-7.3M-9.8M
Q1 '2371M78M53M-9.2M-12M
Q4 '2286M82M63M700,000-1.3M
Q3 '2270M80M51M-16M-14M

Insider Transactions

Dearen Danny L. filed to sell 23,777 shares at $56.9.
October 3 '23
Ford Alfred J Jr filed to sell 34,565 shares at $62.3.
August 17 '23
Ford Alfred J Jr filed to sell 49,334 shares at $62.
August 1 '23
Dearen Danny L. filed to sell 9,202 shares at $50.1.
May 31 '23
Dearen Danny L. filed to sell 17,201 shares at $60.5.
April 25 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.